Stock screenerAll disclosures →
EDGAR →
PGEN
Conviction 90HealthcareScan · Thu, Sep 24, 2026Precigen, Inc. (PGEN) closed at $7.70 (+3.49%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 60, RS Rating 97, -2.4% from its 52-week high, +79.9% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.
PGEN$7.70+3.49%
ResistanceSupportVol 14Insider buyInsider sell2
2
Vol MA14 4.75M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Price7.70
Change+3.49%
Gap-0.81%
Rel volume1.51×
Avg volume4.29M
Avg $ vol31.63M
SMA 207.20
SMA 506.68
SMA 2004.87
Price vs 50+15.33%
Price vs 200+58.15%
MA stackbullish
50/200 cross—
Supertrendup · 6.83
RSI (14)60
MACD hist0.03
MACD crossbull · 5d
Stoch %K / %D77 / 76
ADX (14)24
+DI / −DI28 / 18
RSI divergence—
MACD divergence—
ATR %5.07%
ADR %4.49%
52w high7.89
52w low3.10
From 52w high-2.41%
Above 52w low+148.39%
New 52w highNo
SqueezeOff
Bollinger width21.51%
%B0.82
Donchian pos77.33%
Donchian high8.04
Donchian low6.54
AVWAP (52w high)7.65
vs AVWAP high+0.66%
AVWAP (52w low)4.80
vs AVWAP low+60.56%
OBV trendFlat
Chaikin MF (20)0.11
Today vs 20d1.51×
Avg vol (14d)4.75M
Avg vol (20d)4.29M
Avg $ vol (20d)31.63M
Market cap2.76B
RS Rating97 / 99
RS 3m (vs SPY)+35.00%
RS 6m (vs SPY)+131.57%
RS line new highNo
Trend template8/8
Technical rank93.9
1 week-2.16%
1 month+5.77%
3 months+39.49%
6 months+148.39%
1 year+107.55%
YTD+79.91%
P/E-11.00
P/B63.27
P/S284.68
P/FCF-30.69
EPS-1.37
Div yield—
ROE-575.18%
ROA-147.18%
Debt/Eq3.15
Current4.58
EV/EBITDA-26.82
Gross margin—
Net margin—
Rev growth146.73%
EPS growth-98.55%
Price target18.00
Target upside133.77%
Analyst ratingBuy
Institutional42.31%
Ent. value2.88B
Revenue54.98M
Net income20.07M
Gross profit—
Free cash flow-89.83M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out—
Employees47
ListedThu, Aug 8, 2013
Free float174.65M
Float %49.0%
Short interest42.18M
Days to cover7.9d
Short volume71.5%
Squeeze score93 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.05 vs −$0.02
Last surprise+350.0% beat
Setup gradeA+
Conviction90 / 100
Pattern quality—
Tech rank93.9 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance7.88
Support6.31
Days since event—
Candle confirm—
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- Precigen Receives FDA Platform Technology Designation for AdenoVerse PlatformPR Newswire · Mon, Sep 21, 2026
Congress activity
Disclosed STOCK Act trades in PGEN
No recent disclosed trades by Congress in PGEN. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in PGEN · open-market 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
KINDLER JEFFREY B Director · Common Stock · 2026-08-26 | Sell | 185K | $1.4M | 2026-08-26 | 2026-08-28 |
Shah Rutul R Chief Operating Officer · Option to Purchase Common Stock (Right to Buy) · 2026-08-25 | Exercise | 15.34K | — | 2026-08-25 | 2026-08-25 |
Tennant Phil Chief Commercial Officer · Option to Purchase Common Stock (Right to Buy) · 2026-08-25 | Exercise | 79.17K | — | 2026-08-25 | 2026-08-25 |
Tennant Phil Chief Commercial Officer · Common Stock · 2026-08-25 | Sell | 79.17K | $594K | 2026-08-25 | 2026-08-25 |
Shah Rutul R Chief Operating Officer · Common Stock · 2026-08-25 | Exercise | 15.34K | $36K | 2026-08-25 | 2026-08-25 |
Tennant Phil Chief Commercial Officer · Common Stock · 2026-08-25 | Exercise | 79.17K | $127K | 2026-08-25 | 2026-08-25 |
Shah Rutul R Chief Operating Officer · Common Stock · 2026-08-25 | Sell | 15.34K | $115K | 2026-08-25 | 2026-08-25 |
Sabzevari Helen President and CEO · Restricted Stock Units · 2026-08-23 | Exercise | 20.83K | — | 2026-08-23 | 2026-08-25 |
Tennant Phil Chief Commercial Officer · Common Stock · 2026-08-23 | Tax | 2.58K | $19K | 2026-08-23 | 2026-08-25 |
Tennant Phil Chief Commercial Officer · Restricted Stock Units · 2026-08-23 | Exercise | 5.21K | — | 2026-08-23 | 2026-08-25 |
SEC filings
EDGAR filings in PGEN · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.